Kenvue Inc. $KVUE Shares Purchased by Focus Partners Wealth

Key Points

• Focus Partners Wealth increased its stake in Kenvue Inc. by 20.2%, owning approximately 1.88 million shares valued at around $45.1 million after a recent purchase.
• Kenvue reported a quarterly earnings per share (EPS) of $0.29, slightly beating analysts' expectations, but noted a 4% decrease in revenue compared to the same period last year.
• The company has recently increased its quarterly dividend to $0.2075 per share, representing an annual yield of 4.5% for investors.

Focus Partners Wealth lifted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 20.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,881,219 shares of the company's stock after purchasing an additional 316,651 shares during the quarter. Focus Partners Wealth owned about 0.10% of Kenvue worth $45,112,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Evergreen Wealth Solutions LLC increased its position in shares of Kenvue by 2.6% in the first quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock valued at $402,000 after buying an additional 432 shares in the last quarter. Fulton Bank N.A. raised its holdings in shares of Kenvue by 0.6% in the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after purchasing an additional 465 shares during the period. Scott & Selber Inc. raised its holdings in shares of Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after buying an additional 475 shares during the period. Wealth Alliance LLC increased its holdings in Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock worth $762,000 after purchasing an additional 486 shares during the last quarter. Finally, Everett Harris & Co. CA increased its holdings in Kenvue by 1.4% during the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock worth $887,000 after purchasing an additional 500 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. reduced their price objective on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a research report on Friday, July 25th. Canaccord Genuity Group dropped their price objective on Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Evercore ISI cut their target price on Kenvue from $25.00 to $23.00 and set an "in-line" rating on the stock in a research report on Monday. Barclays lowered their price target on Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Tuesday, July 15th. Finally, Royal Bank Of Canada lowered their target price on Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research note on Friday, August 8th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $24.21.

Kenvue Trading Down 2.2%

KVUE stock opened at $18.46 on Thursday. The business has a fifty day moving average price of $21.23 and a 200 day moving average price of $22.30. Kenvue Inc. has a fifty-two week low of $17.15 and a fifty-two week high of $25.17. The stock has a market capitalization of $35.42 billion, a price-to-earnings ratio of 24.94, a P/E/G ratio of 2.71 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period last year, the company earned $0.32 EPS. The business's quarterly revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.5%. The ex-dividend date of this dividend was Wednesday, August 13th. This is a boost from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio (DPR) is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.